Important information for patients using Actrapid, Insulatard, and Mixtard insulins
The University Multiprofile Hospital for Active Treatment (UMHAT) in Burgas is organizing a campaign for free consultations. The reason is the discontinuation of sales of popular insulin products effective May 31, 2027.
Patients must not change their treatment on their own! The switch must be performed only after consultation with a specialist.
Which products are being withdrawn from the market?
- Actrapid Penfill 100 IU/ml
- Insulatard Penfill 100 IU/ml
- Mixtard 30 Penfill 100 IU/ml
How to get a consultation at UMHAT Burgas?
Every weekday from 10:00 AM to 12:00 PM at the Endocrinology Department. A referral is not required. You can also book an appointment via email.
Dr. Stefka Stefanova, head of the department, assures that the transition to modern bioidentical insulins will be smooth and risk-free for the patients' health.